JUBLPHARMA

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
Jubilant Pharmova Limited

Jubilant Pharmova Limited, an integrated pharmaceutical company in the Healthcare sector (Drug Manufacturers - Specialty & Generic), operates in India, the Americas, Europe, and in...

हिन्दी में

Jubilant Pharmova Limited, Healthcare सेक्टर (ड्रग मैन्युफैक्चरर्स - स्पेशलिटी और जेनेरिक) में एक इंटीग्रेटेड फार्मास्युटिकल कंपनी है, जो भारत, अमेरिका, यूरोप और अंतरराष्ट्रीय स्तर...

₹931.9-0.03%1D
Previous trading day close · Data updates after market close
1W: -5.1%
1M: -8.5%
6M: +4.6%
1Y: -15.0%
55/100
AverageResearch Score
Market Cap
₹15.3K Cr
Mid Cap
P/E Ratio
42.03
Premium
P/B Ratio
2.08
Reasonable
ROE
14.4%
Decent
ROCE
6.3%
Average
Debt / Equity
0.51
Moderate
Div. Yield
0.5%
Low yield
EV/EBITDA
16.07
Fair
52W Low: ₹786.05Current: ₹931.952W High: ₹1,184.8
At 37% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
57/100
Growth
Revenue, EPS, profit growth
54/100
Valuation
PE, PB, EV/EBITDA vs sector
51/100
Risk
Debt levels, volatility, coverage
64/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
42.03(Premium)
Forward P/E
18.44(Attractive)
P/B Ratio
2.08(Reasonable)
P/S Ratio
1.71(Good)
EV/EBITDA
16.07(Expensive)
Dividend Yield
0.5%
5Y CAGR
6.0%(Moderate)
Revenue Growth
17.3%(Moderate)
Profitability
ROE
14.4%(Average)
ROCE
6.3%(Average)
ROA
7.0%(Average)
Net Margin
4.1%(Low)
EBITDA Margin
15.3%
Financial Health
Debt to Equity
0.51(Moderate)
Current Ratio
1.65(Healthy)
Quick Ratio
1.13(Good)
Interest Coverage
4.05x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
20(Oversold)
RSI Exp (14)
5(Oversold)
MACD
-1.109(Bearish)
MACD Signal
15.778
BB Position
-1%(Lower band)
BB Width
16.82%(Normal)
ADX (14)
45.0(Strong trend)
Williams %R
-91.8(Oversold)
MFI (14)
21(Neutral)
CCI (20)
-176(Oversold)
Stoch %K
8(Oversold)
ATR (14)
37.47(Avg True Range)
OBV (M)
11.9(Positive)
1W OBV Chg
-5.1%(Decreasing)
Rel Volume
0.43x(Low activity)
Volatility
36.0%(Moderate)
Max DD 1Y
-36.0%(Moderate)
Alpha (CAPM)
-12.66%(Underperforming)
Return vs Nifty
-3.5%(Below Nifty)
EMA 200
976.6
EMA 50
978.0
SMA 200
954.4
vs SMA 50
-2.5%(Below SMA50)
vs SMA 200
-2.4%(Below SMA200)
Volume
1.23L
Avg Vol 3M
2.9L
Shareholding Pattern
Promoter
47.7%
Moderate
FII
15.9%
DII / MF
11.6%
Share JUBLPHARMA
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.